Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:4893501.
doi: 10.1155/2016/4893501. Epub 2016 Nov 30.

Concomitant Prevalence of Low Serum Diamine Oxidase Activity and Carbohydrate Malabsorption

Affiliations

Concomitant Prevalence of Low Serum Diamine Oxidase Activity and Carbohydrate Malabsorption

Dietmar Enko et al. Can J Gastroenterol Hepatol. 2016.

Abstract

The aim of this retrospective study was to analyze the concomitant prevalence rates for lactose malabsorption (LM), fructose malabsorption (FM), and histamine intolerance (HI) in patients with so far unexplained gastrointestinal (GI) symptoms. A total of 439 outpatients, who presented unclear abdominal discomfort, underwent lactose (50 g) and fructose (25 g) hydrogen (H2) breath tests. Additionally, serum diamine oxidase (DAO) measurements were performed. Individuals with low serum DAO activity (<10 U/mL), GI symptoms, and response to histamine-free diet were diagnosed with HI. Of all 439 patients, 341 (77.7%) were found with 7 various GI conditions. In total, 94 (21.4%), 31 (7.1%), and 100 (22.8%) individuals presented LM, FM, or HI only, whereas 116 (26.4%) patients showed an overlap of GI entities investigated here. Interestingly, 89 out of 241 (36.9%) individuals with carbohydrate malabsorption were also diagnosed with HI (LM + HI: 52 [11.8%], FM + HI: 23 [5.2%], and LM + FM + HI 14 [3.2%] individuals). In conclusion different combinations of LM, FM, and HI are present in individuals with unclear abdominal discomfort/pain. In clinical practice we suggest testing for LM, FM, and additional HI in the diagnostic work-up of these patients. Depending on these various diagnoses possible, patients should get an individualized dietary advice.

PubMed Disclaimer

Conflict of interest statement

Wolfgang J. Schnedl is cofounder of GedoMed GmbH (Bruck an der Mur, Austria). The other authors have no competing interests.

References

    1. Born P. Carbohydrate malabsorption in patients with non-specific abdominal complaints. World Journal of Gastroenterology. 2007;13(43):5687–5691. doi: 10.3748/wjg.v13.i43.5687. - DOI - PMC - PubMed
    1. Goebel-Stengel M., Stengel A., Schmidtmann M., van der Voort I., Kobelt P., Mönnikes H. Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption. Journal of Neurogastroenterology and Motility. 2014;20(2):228–235. doi: 10.5056/jnm.2014.20.2.228. - DOI - PMC - PubMed
    1. Enko D., Kriegshäuser G., Kimbacher C., Stolba R., Mangge H., Halwachs-Baumann G. Carbohydrate malabsorption and putative carbohydrate-specific small intestinal bacterial overgrowth: prevalence and diagnostic overlap observed in an Austrian outpatient center. Digestion. 2015;92(1):32–38. doi: 10.1159/000430981. - DOI - PubMed
    1. Usai-Satta P., Scarpa M., Oppia F., Cabras F. Lactose malabsorption and intolerance: what should be the best clinical management? World Journal of Gastrointestinal Pharmacology and Therapeutics. 2012;3(3):29–33. doi: 10.4292/wjgpt.v3.i3.29. - DOI - PMC - PubMed
    1. Jones H. F., Butler R. N., Brooks D. A. Intestinal fructose transport and malabsorption in humans. American Journal of Physiology—Gastrointestinal and Liver Physiology. 2011;300(2):G202–G206. doi: 10.1152/ajpgi.00457.2010. - DOI - PubMed

MeSH terms

LinkOut - more resources